HEALTH OF WOMAN. 2019.2(138): 37–41; doi 10.15574/HW.2019.138.37

Zhabitskaya L. A.
Bogomolets National Medical University, Kiev

The article presents a comprehensive analysis of modern data on severe disorder of pregnancy – HELLP-syndrome. New data on the prevalence, risk factors and pathogenesis of this pathology are presented, clinical symptoms and diagnostic criteria are described. The systematization of the results of recent studies has made it possible to formulate the features of differential diagnosis of HELLP-syndrome with so-called imitators of this pathology. According to the latest recommendations of FIGO and the main clinical guidlines, management of pregnant women with HELLP-syndrome are given. There are also recommendations for platelet transfusion (with/without other blood products) based on the platelet count, delivery method, active bleeding and coagulopathy.

Key words: HELLP-syndrome, diagnostic criteria, treatment.

REFERENCES

1. Venckivska IB, Zhabitska LA, Zagorodnya OS et al. (2017). Extreme conditions in obstetrics and gynecology. Kiyv, RA-GARMONIA.166.

2. Abildgaard U, Heimdal K. (2013). Pathogenesis of the syndrome of hemolysis, elevated liver enzymes, and low platelet count (HELLP): a review. Eur J Obstet Gynecol Reprod Biol.  166:117. https://doi.org/10.1016/j.ejogrb.2012.09.026

3. American College of Obstetricians and Gynecologists, Task Force on Hypertension in Pregnancy. (2013, Nov). Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol 122(5):1122–1131.

4. Baha M Sibai. (2017, Sep). MD. HELLP syndrome.

5. Burke SD, Zsengellér ZK, Khankin EV et al. (2016). Soluble fms-like tyrosine kinase 1 promotes angiotensin II sensitivity in preeclampsia. J Clin Invest 126:2561. https://doi.org/10.1172/JCI83918

6. Chappell LC, Enye S, Seed P, Briley AL, Poston L, Shennan AH. (2008, Apr). Adverse perinatal outcomes and risk factors for preeclampsia in women with chronic hypertension: a prospective study. Hypertension 51(4):1002–9. https://doi.org/10.1161/HYPERTENSIONAHA.107.107565

7. Committee on Obstetric Practice. Committee Opinion 623. (2015, Feb). Emergent therapy for acute-onset, severe hypertension during pregnancy and the postpartum period. Obstet Gynecol 125(2): 521–525. https://doi.org/10.1097/01.AOG.0000460762.59152.d7

8. Errol R Norwitz, MD, PhD, MBAJohn T Repke, MD. (2017, Aug 03). Preeclampsia: Management and prognosis.

9. Estcourt LJ, Ingram C, Doree C et al. (2016). Use of platelet transfusions prior to lumbar punctures or epidural anaesthesia for the prevention of complications in people with thrombocytopenia. Cochrane Database Syst Rev:CD011980. https://doi.org/10.1002/14651858.CD011980.pub2

10. Gordon A, Raynes-Greenow C, Bond D et al. (2015). Sleep position, fetal growth restriction, and late-pregnancy stillbirth: the Sydney stillbirth study. Obstet Gynecol 125:347. https://doi.org/10.1097/AOG.0000000000000627

11. Gradman AH, Basile JN, Carter BL, Bakris GL, American Society of Hypertension Writing Group. (2010, Jan-Feb). Combination therapy in hypertension. J Am Soc Hypertens 4(1):42–50. https://doi.org/10.1016/j.jash.2010.02.005

12. Lowe SA, Bowyer L, Lust K, McMahon LP, Morton MR, North RA et al. (2014). The SOMANZ guideline for the management of hypertensive disorders of pregnancy. Sydney, SOMANZ. https://doi.org/10.1111/ajo.12253

13. Minakami H, Morikawa M, Yamada T et al. (2014). Differentiation of acute fatty liver of pregnancy from syndrome of hemolysis, elevated liver enzymes and low platelet counts. J Obstet Gynaecol Res 40:641. https://doi.org/10.1111/jog.12282

14. National Collaborating Centre for Women’s and Children’s Health (UK). (2010, Aug). CG107: Hypertension in pregnancy. The management of hypertensive disorders during pregnancy. NICE: Guidance.

15. National Institutes of Health. Drugs and Lactation Database (LactMed). (2015). Available at: http://toxnet.nlm.nih.gov/newtoxnet/lactmed.htm. Accessed 2015, March 16.

16. Roberts JM, August PA, Bakris G, Barton JR, Bernstin IM. (2013). The American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Hypertension in Pregnancy. Obstetrics & Gynecology 122(5):1122–1131.

17. Seal SL, Ghosh D, Kamilya G et al. (2012). Does route of delivery affect maternal and perinatal outcome in women with eclampsia? A randomized controlled pilot study. Am J Obstet Gynecol 206:484.e1. https://doi.org/10.1016/j.ajog.2012.04.009

18. The Figo Textbook of Pregnancy Hypertension. An evidence-based guide to monitoring, prevention and management: 456. 2016.

19. van Dijk M, Thulluru HK, Mulders J et al. (2012). HELLP babies link a novel lincRNA to the trophoblast cell cycle. J Clin Invest  122:4003. https://doi.org/10.1172/JCI65171

20. World Health Organization. (2011). WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia. Geneva, WHO.

21. Zeisler H, Llurba E, Chantraine F et al. (2016). Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia. N Engl J Med 374:13. https://doi.org/10.1056/NEJMoa1414838